Analysis of the premalignant stages of Barrett's oesophagus through to adenocarcinoma by comparative genomic hybridization

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 11, 2002, Pages 1179-1186

  Croft, Jeanette ^a   Parry, Elizabeth M ^a   Jenkins, Gareth J S ^a   Doak, Shareen H ^a   Baxter, John N ^b   Griffiths, A Paul ^b   Brown, Tim H ^b   Parry, James M ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Chromosome stability; Comparative genomic hybridization

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER SUSCEPTIBILITY; CHROMOSOME 4; CHROMOSOME 8Q; CHROMOSOME VARIANT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DYSPLASIA; GASTROESOPHAGEAL REFLUX; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; KARYOTYPING; PRECANCER; PRIORITY JOURNAL; TECHNIQUE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CHROMOSOME MAPPING; DNA MUTATIONAL ANALYSIS; ESOPHAGEAL NEOPLASMS; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASM STAGING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; PRECANCEROUS CONDITIONS;

EID: 0036866676     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200211000-00004     Document Type: Article

References (29)

1. Jenkins GJS, Doak SH, Parry JM, D'Souza FR, Griffiths AP, Baxter JN. Genetic pathways involved in the progression of Barrett's oesophagus to adenocarcinoma. British J Surg 2002; 89:824-838.
2. Morales CP, Lee EL, Shay JW. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer 1998; 83:652-659.
3. Manjunath S, Jankowski JA. Interaction of environmental factors in oesophageal carcinogenesis [abstract]. JR Coll Surg Edinb 2000; 45:260-262.
4. Watson A. Barrett's oesophagus: 50 Years on. Br J Surgery 2000; 87:529-531.
5. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New Engl J Med 1999; 340:825-831.
6. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours. Science 1992; 258:818-821.
7. Speicher MR, du Manoir S, Schrock E, Holtgreve-Grez H, Schoell B, Lengauer C, et al. Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumours by comparative genomic hybridization after universal DNA-amplification. Hum Mol Genet 1993; 2:1907-1914.
8. Dolan K, Garde J, Walker SJ, Sutton R, Gosney J, Field JK. LOH at the sites of DCC, APC and TP53 tumour suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. Hum Pathol 1999; 30: 1508-1514.
9. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999; 154:-965-973.
10. Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nature Genet 1999; 22:106-109.
11. Walch AK, Zitzelsberger HF, Bruch J, Keller G, Angermeier D, Aubele MM, et al. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol 2000; 156:555-566.
12. Reigman PHJ, Vissers KJ, Alers JC, Geelen E, Hop WCJ, Tilanus HW, van Dekken H. Genomic alterations in malignant transformation of Barrett's esophagus. Cancer Res 2001; 61:3164-3170.
13. Van Dekken H, Vissers CJ, Tilanus HW, Tanke HJ, Rosenberg C. Clonal analysis of a case of multifocal oesophageal (Barrett's) adenocarcinoma by comparative genomic hybridisation. J Pathol 1999; 188:263-266.
14. Walch AK, Ztzelberger HF, Bink K, Hutzler P, Bruch J, Braselmann H, et al. Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases: Comparison with nonmetastatic Barrett's adenocarcinoma. Modern Pathol 2000; 13:814-824.
15. Kuukasjarvi T, Tanner M, Pennanen S, Karhu R, Visakorpi T, Isola J. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes Cancer 1997; 18:94-101.
16. Giaretti W. Aneuploidy mechanisms in human colorectal preneoplastic lesions and Barrett's oesophagus. Is there a role for K-ras and p53 mutations. Anal Cell Path 1997; 15:99-117.
17. SH Doak, GJS Jenkins, AP Griffiths, EM Parry, JM Parry, JN Baxter. Interphase Fluoresence In Situ Hybridisation (FISH) on Barrett's oesophagus as it progresses to adenocarcinoma. Gut 2002, 50(Suppl. 2):A5.
18. Persons DL, Croughan WS, Borelli KA, Cherian R. Interphase cytogenetics of esophageal adenocarcinoma and precursor lesions. Cancer Genet Cytogenet 1998; 106:11-17.
19. Hammoud ZT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA, Goodfellow PJ. Allelotype analysis of esophageal adenocarcinomas: Evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res 1996; 56:4499-4502.
20. MenkePluymers MBE, Van Drunen E, Vissers KJ, Mulder AH, Tilanus HW, Hagemeijer A. Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. Cancer Genet Cytogenet 1996; 90:109-117.
21. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997; 277:965-968.
22. Ghadimi BM, Schrock E, Walker RL, Wangsa D, Jauho A, Meltzer PS, Ried T. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am J Pathol 1999; 154:525-536.
23. Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang S, et al. Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 1998; 95:8703-8708.
24. Savelieva E, Belair CD, Newton MA, DeVries S, Gray JW, Waldman F, Reznikoff CA. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene 1997; 14:551-560.
25. Bai C, Connolly B, Metzker ML, Hilliard CA, Liu X, Sandig V, et al. Overexpression of M68/DcR3 in human gastrointestinal tract tumours independent of gene amplification and its location in a four gene duster. Proc Natl Acad Sci USA 2000; 97:1230-1235.
26. Maitra A, Wistuba II, Washington C, Virmani AK, Ashfaq R, Milchgrub S, et al. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol 2001; 159:119-130.
27. Reid B J, Sanchez C A, Blount PL, Levine DS. Barrett's oesophagus: Cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993; 105:119-129.
28. Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WC, Teijgeman R, Mulder AH, et al. Accumulation of genetic abnormalities during neoplastic progression in Barrett's oesophagus. Cancer Res 1995; 55:1971-1976.
29. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 1996; 12:1873-1878.